Grants per year
Grants 2004 2021
Finished
Prot #8400-211: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of IMO-8400 In Patients with Dermatomyositis
Parexel, Idera Pharmaceuticals, Inc.
3/14/16 → 3/14/19
Project: Research project
Prot #CC-220-SLE-001: A PILOT, PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, STUDY TO EVALUATE EFFICACY, SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND PHARMACOGENETICS OF CC-220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
PPD Development, Celgene Corporation
4/7/15 → 4/7/19
Project: Research project
Prot #X052171: A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients with Pyoderma Gangrenosum
Therapeutics, Inc., XOMA (US) LLC
3/19/15 → 3/19/18
Project: Research project
Efficacy of Ustekinumab (Anti-IL_12/23) followed by Abatcept (CTLA4-lg) for the tretment of Psoriasis Vulgaris
Benaroya Research Institute at Virginia Mason, National Institute of Allergy and Infectious Diseases
9/1/14 → 10/31/18
Project: Research project
Interleukin-23
Interleukin-12
Psoriasis
Recurrence
Ustekinumab
Clinical and molecular Characterization of lichen Sclerosus as a Model of Vulvar Epithelial Fibrosis
Laumann, A. E. & Schlosser, B. J.
7/1/12 → 6/30/15
Project: Research project
Prot# CNTO1959PSO2001: A Phase 2 Multicenter, Randomized, Placebo- and Active-Comparator-Controlled, Dose-Ranging Trial to Evaluate CNTO 1959 for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis (X-PLORE)
Gordon, K. B., Laumann, A. E. & West, D. P.
Parexel, Janssen Research & Development, LLC
5/4/12 → 5/4/15
Project: Research project
Prot#R668-AD-0914: A Randomized, Double-Blind, Placebo-Controlled, Sequential Ascending, Repeated-Dose Study of the Safety and Pharmacokinetics of Subcutaneous REGN668 in Patients with Moderate-to-Severe Extrinsic Atopic Dermatitis
Laumann, A. E., Paller, A. & West, D. P.
Ingenix Pharmaceutical Services, Inc., Regeneron Pharmaceuticals, Inc.
2/1/11 → 2/1/14
Project: Research project
Prot# BAP01346: Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Dago, P. L., Laumann, A. E., Martini, M. C. & West, D. P.
Covance Periapproval Services, Inc., Basilea Pharmaceutica International Ltd.
5/26/09 → 5/26/12
Project: Research project
Tadalafil for the Treatment of Secondary Raynaud's Phenomenon
5/19/08 → 5/19/11
Project: Research project
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA-BN (IMVAMUNE) Smallpox Vaccine in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
Bavarian Nordic A/S, National Institute of Allergy and Infectious Diseases
3/1/08 → 2/28/10
Project: Research project
Prot# C-2006-004-03: A Double-Blind, Randomized, Placebo-Controlled, Sequential Cohort Exploratory Study of the Safety and Efficacy of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis that is Moderate in Severity
Laumann, A. E., Paller, A. & West, D. P.
Janssen Research & Development, LLC
4/2/07 → 4/2/08
Project: Research project
Prot: Evaluation of the Moisturizing Properties of a Hyaluronic Acid Based Oral Moisturizer Spray in ICU Intubated Patients
Laumann, A. E., West, D. P. & Wunderink, R. G.
2/16/07 → 2/16/08
Project: Research project
Prot# CTA018-CL-2001-1: A Randomized, Double-Blind, Parallel-Group, 4-Arm, 12 Week Study to Evaluate the Safety and Efficacy of Topically Applied CTA018 vs. Vehicle for the Treatment of Adult Subjects with Chronic Plaque Psoriasis
Laumann, A. E., Singri, P. & West, D. P.
8/17/06 → 1/3/08
Project: Research project
Prot# SS-0601: TheraGauze Alone and Regranex® Gel 0.01% plus TheraGauze In the Treatment of Wagner Stage I Diabetic Foot Ulcers
Alam, M., Laumann, A. E. & West, D. P.
7/17/06 → 5/31/08
Project: Research project